Terms ending in 2038
Every in-force patent on Biogen Ma Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,484,278 | Assessment of Labeled Probes in a Subject In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence | |
| US 10,342,738 | Medical Metering Device In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,168,095 | ASK1 Inhibiting Agents In force (reinstated) · High confidence | Biogen Ma Inc. | In force (reinstated) | High confidence | |
| US 11,203,601 | Tricyclic Compounds as Glycogen Synthase Kinase 3 (GSK3) Inhibitors and Uses Thereof In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,602,530 | CRM1 Inhibitors for Treating Epilepsy In force · High confidence | Karyopharm Therapeutics Inc. | In force | High confidence | |
| US 10,189,829 | Inhibiting Agents for Bruton's Tyrosine Kinase In force · Low confidence | Biogen Ma Inc. | In force | Low confidence | |
| US 10,227,341 | Inhibiting Agents for Bruton's Tyrosine Kinase In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 10,961,237 | Inhibiting Agents for Bruton's Tyrosine Kinase In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence | |
| US 11,427,577 | Inhibiting Agents for Bruton's Tyrosine Kinase In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence | |
| US 11,858,926 | Inhibiting Agents for Bruton's Tyrosine Kinase In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| 6 more term ends in 2038 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
14 of these are in force and held by Biogen Ma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.